Literature DB >> 33382057

Classification of heart failure: A farewell to ejection fraction?

Thomas F Lüscher1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33382057      PMCID: PMC7803805          DOI: 10.14744/AnatolJCardiol.2020.70138

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.475


× No keyword cloud information.
  33 in total

1.  Eplerenone in patients with systolic heart failure and mild symptoms.

Authors:  Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

2.  Deranged Myocyte Microstructure in Situs Inversus Totalis Demonstrated by Diffusion Tensor Cardiac Magnetic Resonance.

Authors:  Zohya Khalique; Pedro F Ferreira; Andrew D Scott; Sonia Nielles-Vallespin; Philip J Kilner; Robert Kutys; Maria Romero; Andrew E Arai; David N Firmin; Dudley J Pennell
Journal:  JACC Cardiovasc Imaging       Date:  2018-01-17

3.  Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.

Authors:  John R Teerlink; Rafael Diaz; G Michael Felker; John J V McMurray; Marco Metra; Scott D Solomon; Kirkwood F Adams; Inder Anand; Alexandra Arias-Mendoza; Tor Biering-Sørensen; Michael Böhm; Diana Bonderman; John G F Cleland; Ramon Corbalan; Maria G Crespo-Leiro; Ulf Dahlström; Luis E Echeverria; James C Fang; Gerasimos Filippatos; Cândida Fonseca; Eva Goncalvesova; Assen R Goudev; Jonathan G Howlett; David E Lanfear; Jing Li; Mayanna Lund; Peter Macdonald; Viacheslav Mareev; Shin-Ichi Momomura; Eileen O'Meara; Alexander Parkhomenko; Piotr Ponikowski; Felix J A Ramires; Pranas Serpytis; Karen Sliwa; Jindrich Spinar; Thomas M Suter; Janos Tomcsanyi; Hans Vandekerckhove; Dragos Vinereanu; Adriaan A Voors; Mehmet B Yilmaz; Faiez Zannad; Lucie Sharpsten; Jason C Legg; Claire Varin; Narimon Honarpour; Siddique A Abbasi; Fady I Malik; Christopher E Kurtz
Journal:  N Engl J Med       Date:  2020-11-13       Impact factor: 91.245

4.  Spironolactone for heart failure with preserved ejection fraction.

Authors:  Bertram Pitt; Marc A Pfeffer; Susan F Assmann; Robin Boineau; Inder S Anand; Brian Claggett; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Brian Harty; John F Heitner; Christopher T Kenwood; Eldrin F Lewis; Eileen O'Meara; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Song Yang; Sonja M McKinlay
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

5.  Effect of carvedilol on survival in severe chronic heart failure.

Authors:  M Packer; A J Coats; M B Fowler; H A Katus; H Krum; P Mohacsi; J L Rouleau; M Tendera; A Castaigne; E B Roecker; M K Schultz; D L DeMets
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

6.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Authors:  Scott D Solomon; John J V McMurray; Inder S Anand; Junbo Ge; Carolyn S P Lam; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Margaret M Redfield; Jean L Rouleau; Dirk J van Veldhuisen; Faiez Zannad; Michael R Zile; Akshay S Desai; Brian Claggett; Pardeep S Jhund; Sergey A Boytsov; Josep Comin-Colet; John Cleland; Hans-Dirk Düngen; Eva Goncalvesova; Tzvetana Katova; Jose F Kerr Saraiva; Małgorzata Lelonek; Bela Merkely; Michele Senni; Sanjiv J Shah; Jingmin Zhou; Adel R Rizkala; Jianjian Gong; Victor C Shi; Martin P Lefkowitz
Journal:  N Engl J Med       Date:  2019-09-01       Impact factor: 91.245

7.  Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults.

Authors:  Sujata M Shanbhag; Anders M Greve; Thor Aspelund; Erik B Schelbert; J Jane Cao; Ragnar Danielsen; Guðmundur Þorgeirsson; Sigurður Sigurðsson; Guðný Eiríksdóttir; Tamara B Harris; Lenore J Launer; Vilmundur Guðnason; Andrew E Arai
Journal:  Eur Heart J       Date:  2019-02-07       Impact factor: 29.983

8.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Authors:  M Packer; J R Carver; R J Rodeheffer; R J Ivanhoe; R DiBianco; S M Zeldis; G H Hendrix; W J Bommer; U Elkayam; M L Kukin
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

9.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

Authors:  F Waagstein; M R Bristow; K Swedberg; F Camerini; M B Fowler; M A Silver; E M Gilbert; M R Johnson; F G Goss; A Hjalmarson
Journal:  Lancet       Date:  1993-12-11       Impact factor: 79.321

10.  Optimal diffusion weighting for in vivo cardiac diffusion tensor imaging.

Authors:  Andrew D Scott; Pedro F A D C Ferreira; Sonia Nielles-Vallespin; Peter Gatehouse; Laura-Ann McGill; Philip Kilner; Dudley J Pennell; David N Firmin
Journal:  Magn Reson Med       Date:  2014-08-22       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.